Cas 956697-13-5,1-benzyl 4-tert-butyl 2-cyclopentyl piperazine-1,2,4-tricarboxylate

956697-13-5

Post Buying Request

Basic information

Product Name: 1-benzyl 4-tert-butyl 2-cyclopentyl piperazine-1,2,4-tricarboxylate
Synonyms: 1-benzyl 4-tert-butyl 2-cyclopentyl piperazine-1,2,4-tricarboxylate
CAS NO:956697-13-5
Molecular Formula:
Molecular Weight: 432.517
EINECS: N/A
Product Categories: N/A
Mol File: 956697-13-5.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-benzyl 4-tert-butyl 2-cyclopentyl piperazine-1,2,4-tricarboxylate(CAS DataBase Reference)
NIST Chemistry Reference: 1-benzyl 4-tert-butyl 2-cyclopentyl piperazine-1,2,4-tricarboxylate(956697-13-5)
EPA Substance Registry System: 1-benzyl 4-tert-butyl 2-cyclopentyl piperazine-1,2,4-tricarboxylate(956697-13-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 956697-13-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

956697-13-5 Suppliers

Recommended suppliersmore

956697-13-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 956697-13-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,6,6,9 and 7 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 956697-13:
(8*9)+(7*5)+(6*6)+(5*6)+(4*9)+(3*7)+(2*1)+(1*3)=235
235 % 10 = 5
So 956697-13-5 is a valid CAS Registry Number.

956697-13-5Upstream product

956697-13-5Downstream Products

956697-12-4 1-benzyl 2-cyclopentyl piperazine-1,2-dicarboxylate

956697-13-5Relevant articles and documents

PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER

-

Page/Page column 46, (2008/12/05)

Compound of formula (I) are inhibitors of Polo-like kinases (PLKs), and are useful in treatment of cell proliferative diseases: wherein R1 and R2 are hydrogen, or an optionally substituted (C1-C6)alkyl, (C2- Cs

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 956697-13-5